In vitro–in vivo evaluation of poly(2-hydroxyethyl methacrylate-co-methyl methacrylate) hydrogel implants containing cisplatin
The aim of this study was to prepare hydrogel disc implants containing cisplatin from hydroxyethyl methacrylate (HEMA) and methyl methacrylate (MMA). To control drug release, the monomers were cross-linked with ethyleneglycol dimethacrylate (EGDMA). Implants were characterized by FTIR, DSC and SEM a...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2011-12-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383511000803 |
id |
doaj-d009836210c944dfa9a6452a2bbe7301 |
---|---|
record_format |
Article |
spelling |
doaj-d009836210c944dfa9a6452a2bbe73012020-11-24T22:19:21ZengElsevierActa Pharmaceutica Sinica B2211-38352211-38432011-12-011426126710.1016/j.apsb.2011.09.001In vitro–in vivo evaluation of poly(2-hydroxyethyl methacrylate-co-methyl methacrylate) hydrogel implants containing cisplatinMadhu BabuHemant K.S. YadavAfrasim MoinHosakote G. ShivakumarThe aim of this study was to prepare hydrogel disc implants containing cisplatin from hydroxyethyl methacrylate (HEMA) and methyl methacrylate (MMA). To control drug release, the monomers were cross-linked with ethyleneglycol dimethacrylate (EGDMA). Implants were characterized by FTIR, DSC and SEM and evaluated for drug content, swelling, tensile strength, in vitro and in vivo drug release, in vitro and in vivo biodegradation of the polymer and histopathological studies. The in vitro results showed that increasing the concentration of either MMA or EGDMA decreased drug release and prolonged the implant life. Histopathological studies showed that the implants were histocompatible with surrounding tissue. Stability studies on the optimized formulation showed it was stable over 90 days at 25±3 °C. The implants can be used to achieve controlled release of drug and attain effective treatment with reduced side effects.http://www.sciencedirect.com/science/article/pii/S2211383511000803Controlled releaseSwellingHistocompatibleBiodegradation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Madhu Babu Hemant K.S. Yadav Afrasim Moin Hosakote G. Shivakumar |
spellingShingle |
Madhu Babu Hemant K.S. Yadav Afrasim Moin Hosakote G. Shivakumar In vitro–in vivo evaluation of poly(2-hydroxyethyl methacrylate-co-methyl methacrylate) hydrogel implants containing cisplatin Acta Pharmaceutica Sinica B Controlled release Swelling Histocompatible Biodegradation |
author_facet |
Madhu Babu Hemant K.S. Yadav Afrasim Moin Hosakote G. Shivakumar |
author_sort |
Madhu Babu |
title |
In vitro–in vivo evaluation of poly(2-hydroxyethyl methacrylate-co-methyl methacrylate) hydrogel implants containing cisplatin |
title_short |
In vitro–in vivo evaluation of poly(2-hydroxyethyl methacrylate-co-methyl methacrylate) hydrogel implants containing cisplatin |
title_full |
In vitro–in vivo evaluation of poly(2-hydroxyethyl methacrylate-co-methyl methacrylate) hydrogel implants containing cisplatin |
title_fullStr |
In vitro–in vivo evaluation of poly(2-hydroxyethyl methacrylate-co-methyl methacrylate) hydrogel implants containing cisplatin |
title_full_unstemmed |
In vitro–in vivo evaluation of poly(2-hydroxyethyl methacrylate-co-methyl methacrylate) hydrogel implants containing cisplatin |
title_sort |
in vitro–in vivo evaluation of poly(2-hydroxyethyl methacrylate-co-methyl methacrylate) hydrogel implants containing cisplatin |
publisher |
Elsevier |
series |
Acta Pharmaceutica Sinica B |
issn |
2211-3835 2211-3843 |
publishDate |
2011-12-01 |
description |
The aim of this study was to prepare hydrogel disc implants containing cisplatin from hydroxyethyl methacrylate (HEMA) and methyl methacrylate (MMA). To control drug release, the monomers were cross-linked with ethyleneglycol dimethacrylate (EGDMA). Implants were characterized by FTIR, DSC and SEM and evaluated for drug content, swelling, tensile strength, in vitro and in vivo drug release, in vitro and in vivo biodegradation of the polymer and histopathological studies. The in vitro results showed that increasing the concentration of either MMA or EGDMA decreased drug release and prolonged the implant life. Histopathological studies showed that the implants were histocompatible with surrounding tissue. Stability studies on the optimized formulation showed it was stable over 90 days at 25±3 °C. The implants can be used to achieve controlled release of drug and attain effective treatment with reduced side effects. |
topic |
Controlled release Swelling Histocompatible Biodegradation |
url |
http://www.sciencedirect.com/science/article/pii/S2211383511000803 |
work_keys_str_mv |
AT madhubabu invitroinvivoevaluationofpoly2hydroxyethylmethacrylatecomethylmethacrylatehydrogelimplantscontainingcisplatin AT hemantksyadav invitroinvivoevaluationofpoly2hydroxyethylmethacrylatecomethylmethacrylatehydrogelimplantscontainingcisplatin AT afrasimmoin invitroinvivoevaluationofpoly2hydroxyethylmethacrylatecomethylmethacrylatehydrogelimplantscontainingcisplatin AT hosakotegshivakumar invitroinvivoevaluationofpoly2hydroxyethylmethacrylatecomethylmethacrylatehydrogelimplantscontainingcisplatin |
_version_ |
1725779573538291712 |